Sodium Valproate: Health Services
Commons · Question 106954 · Tabled 20 Jan 2026 · Department of Health and Social Care · Official record
Answered 29 Jan 2026
Question
Asked by Bob Blackman
To ask the Secretary of State for Health and Social Care, what assessment has been made of whether NHS care pathways are adequate for individuals harmed by sodium valproate that require lifelong, multidisciplinary care.
Answer
Answered by Zubir Ahmed, 29 Jan 2026
The Independent Medicines and Medical Devices Safety Review, First Do No Harm, identified significant shortcomings in National Health Service care pathways for people harmed by sodium valproate, including fragmented services, limited diagnostic expertise,...